Vontobel Holding
NVCR icon

Vontobel Holding’s NovoCure NVCR Stock Holding History

Vontobel Holding’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,343
Closed -$222K – 1113
2023
Q2 		$222K Buy
5,343
+939
+21% +$58.3K ﹤0.01% 982
2023
Q1 		$265K Sell
4,404
-900
-17% -$71.9K ﹤0.01% 915
2022
Q4 		$369K Buy
5,304
+2,524
+91% +$190K ﹤0.01% 841
2022
Q3 		$210K Buy
+2,780
New +$217K ﹤0.01% 935
2022
Q1 		– Sell
-4,391
Closed -$350K – 1112
2021
Q4 		$350K Sell
4,391
-1,193
-21% -$120K ﹤0.01% 893
2021
Q3 		$649K Buy
5,584
+1,302
+30% +$197K 0.01% 715
2021
Q2 		$959K Buy
+4,282
New +$833K 0.01% 599

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Vontobel Holding's NVCR Position: Q3 2023 in Review

Vontobel Holding sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 5,343 shares — an estimated $222K sold.

Vontobel Holding first reported a position in NVCR in Q2 2021 and held it in 7 quarters. The position peaked at $959K in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Vontobel Holding reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Vontobel Holding sold 5,343 NovoCure shares in Q3 2023, an estimated $222K.
  • Vontobel Holding first reported a position in NovoCure in Q2 2021 and held it in 7 quarters.
  • Vontobel Holding's NovoCure position peaked at $959K in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Vontobel Holding's 13F filing for Q3 2023, filed 11 Oct 2023.